BlackRock
VCNX

BlackRock’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

BlackRock’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12
Closed -$194 – 5461
2023
Q3 		$194 Hold
12
– – ﹤0.01% 5384
2023
Q2 		$913 Sell
12
-237
-95% -$19.7K ﹤0.01% 5409
2023
Q1 		$20.9K Buy
249
+8
+3% +$879 ﹤0.01% 5250
2022
Q4 		$32.6K Buy
241
+5
+2% +$620 ﹤0.01% 5313
2022
Q3 		$25K Sell
236
-65
-22% -$12.8K ﹤0.01% 5475
2022
Q2 		$68K Buy
301
+75
+33% +$19.2K ﹤0.01% 5350
2022
Q1 		$63K Sell
226
-11
-5% -$3.04K ﹤0.01% 5380
2021
Q4 		$52K Buy
237
+6
+3% +$2.16K ﹤0.01% 5393
2021
Q3 		$105K Sell
231
-5
-2% -$2.5K ﹤0.01% 5127
2021
Q2 		$139K Buy
236
+142
+151% +$75.1K ﹤0.01% 4975
2021
Q1 		$59K Buy
94
+8
+9% +$5.14K ﹤0.01% 4901
2020
Q4 		$37K Buy
86
+12
+16% +$5.02K ﹤0.01% 4703
2020
Q3 		$28K Buy
74
+20
+37% +$21.8K ﹤0.01% 4674
2020
Q2 		$41K Buy
54
+12
+29% +$9.36K ﹤0.01% 4607
2020
Q1 		$35K Buy
42
+11
+35% +$12.5K ﹤0.01% 4536
2019
Q4 		$31K Buy
31
+12
+63% +$13.5K ﹤0.01% 4605
2019
Q3 		$28K Buy
19
+3
+19% +$3.38K ﹤0.01% 4611
2019
Q2 		$18K Buy
16
+13
+433% +$17.3K ﹤0.01% 4704
2019
Q1 		$3K Hold
3
– – ﹤0.01% 4804
2018
Q4 		$2K Hold
3
– – ﹤0.01% 4853
2018
Q3 		$4K Buy
+3
New +$6.19K ﹤0.01% 4839

Other funds holding VCNX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock's VCNX Position: Q4 2023 in Review

BlackRock sold out of Vaccinex, Inc. Common Stock (VCNX) in Q4 2023, closing a stake of 12 shares — an estimated $194 sold.

BlackRock first reported a position in VCNX in Q3 2018 and held it in 21 quarters. The position peaked at $139K in Q2 2021. 17 funds tracked by Wall St. Rank hold VCNX as of Q4 2023.

  • BlackRock reported no remaining Vaccinex, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • BlackRock sold 12 Vaccinex, Inc. Common Stock shares in Q4 2023, an estimated $194.
  • BlackRock first reported a position in Vaccinex, Inc. Common Stock in Q3 2018 and held it in 21 quarters.
  • BlackRock's Vaccinex, Inc. Common Stock position peaked at $139K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q4 2023.

Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.